Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

Core Viewpoint - Scilex Holding Company has made a strategic investment of $20 million in Quantum Scan Holdings, Inc. to support the development of innovative medical technologies aimed at improving healthcare delivery and efficiency [1][2]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [4][6]. - The company targets high unmet needs and large market opportunities with its non-opioid therapies [4]. Investment Details - The investment in Quantum Scan is intended to enhance the development of advanced diagnostic platforms and scalable healthcare solutions [2]. - Scilex believes this investment aligns with its strategic priorities and complements its previous investment in Datavault AI [2][3]. Quantum Scan Holdings, Inc. - Quantum Scan is a medical technology company focused on developing advanced healthcare technologies, including diagnostics and analytics [7]. - The company aims to enhance healthcare delivery and accessibility through innovative medical platforms [7]. Leadership Comments - Mustaq Patel, CEO of Quantum Scan, expressed gratitude for Scilex's investment, emphasizing the need for innovation in medical technologies [3]. - Henry Ji, CEO of Scilex, highlighted Quantum Scan's experienced team and the potential for long-term value creation through this investment [3].